LBRX
LB Pharmaceuticals Inc
44.71
-0.23 (-0.51%)
52w low 14.40
50.16 high
84.8% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 2.81M | 11.38M | 64.83M | 30.40M | |
| R&D | 1.35M | 7.84M | 51.17M | 16.74M | |
| SG&A | 1.46M | 3.53M | 13.66M | 13.66M | |
| Operating Income | -2.81M | -11.38M | -64.83M | -30.40M | |
| EBITDA | -12.19M | -1.45M | -64.74M | -30.08M | |
| Pretax Income | -14.35M | -6.27M | -63.10M | -25.20M | |
| Income Tax | 1.00K | 1.00K | 1.00K | 1.00K | |
| Net Income | -14.35M | -6.28M | -63.10M | -25.20M | |
| EPS Diluted | -4.05 | -1.77 | -17.82 | -3.13 | |
| Diluted Shares | 22.44M | 22.44M | 22.44M | 8.05M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--